<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wikem.org/w/index.php?action=history&amp;feed=atom&amp;title=Arsine_gas_exposure</id>
	<title>Arsine gas exposure - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wikem.org/w/index.php?action=history&amp;feed=atom&amp;title=Arsine_gas_exposure"/>
	<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Arsine_gas_exposure&amp;action=history"/>
	<updated>2026-04-16T01:45:38Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.38.2</generator>
	<entry>
		<id>https://wikem.org/w/index.php?title=Arsine_gas_exposure&amp;diff=389236&amp;oldid=prev</id>
		<title>Danbot: Strip excess bold</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Arsine_gas_exposure&amp;diff=389236&amp;oldid=prev"/>
		<updated>2026-03-22T09:30:25Z</updated>

		<summary type="html">&lt;p&gt;Strip excess bold&lt;/p&gt;
&lt;a href=&quot;//wikem.org/w/index.php?title=Arsine_gas_exposure&amp;amp;diff=389236&amp;amp;oldid=386220&quot;&gt;Show changes&lt;/a&gt;</summary>
		<author><name>Danbot</name></author>
	</entry>
	<entry>
		<id>https://wikem.org/w/index.php?title=Arsine_gas_exposure&amp;diff=386220&amp;oldid=prev</id>
		<title>Danbot: Moved intro into Background as bullets; removed excessive bold from bullet lead-ins; added Toxic gas exposure DDX and Hemolytic anemia DDX templates</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Arsine_gas_exposure&amp;diff=386220&amp;oldid=prev"/>
		<updated>2026-03-19T15:06:22Z</updated>

		<summary type="html">&lt;p&gt;Moved intro into Background as bullets; removed excessive bold from bullet lead-ins; added Toxic gas exposure DDX and Hemolytic anemia DDX templates&lt;/p&gt;
&lt;a href=&quot;//wikem.org/w/index.php?title=Arsine_gas_exposure&amp;amp;diff=386220&amp;amp;oldid=386150&quot;&gt;Show changes&lt;/a&gt;</summary>
		<author><name>Danbot</name></author>
	</entry>
	<entry>
		<id>https://wikem.org/w/index.php?title=Arsine_gas_exposure&amp;diff=386150&amp;oldid=prev</id>
		<title>Ostermayer: Created page with &quot;Arsine gas (AsH₃) is the most acutely toxic form of arsenic. It is a colorless, nonirritating gas that causes '''massive intravascular hemolysis''' leading to '''acute renal failure''' and death. Arsine poisoning is '''distinct from inorganic arsenic poisoning''' — it does not produce classic arsenicosis, and '''chelation therapy is not effective.'''&lt;ref name=&quot;ATSDR&quot;&gt;Arsine Medical Management Guidelines. Agency for Toxic Substances and Disease Registry (ATSDR). CDC.&lt;...&quot;</title>
		<link rel="alternate" type="text/html" href="https://wikem.org/w/index.php?title=Arsine_gas_exposure&amp;diff=386150&amp;oldid=prev"/>
		<updated>2026-03-17T23:31:57Z</updated>

		<summary type="html">&lt;p&gt;Created page with &amp;quot;Arsine gas (AsH₃) is the most acutely toxic form of arsenic. It is a colorless, nonirritating gas that causes &amp;#039;&amp;#039;&amp;#039;massive intravascular hemolysis&amp;#039;&amp;#039;&amp;#039; leading to &amp;#039;&amp;#039;&amp;#039;acute renal failure&amp;#039;&amp;#039;&amp;#039; and death. Arsine poisoning is &amp;#039;&amp;#039;&amp;#039;distinct from inorganic arsenic poisoning&amp;#039;&amp;#039;&amp;#039; — it does not produce classic arsenicosis, and &amp;#039;&amp;#039;&amp;#039;chelation therapy is not effective.&amp;#039;&amp;#039;&amp;#039;&amp;lt;ref name=&amp;quot;ATSDR&amp;quot;&amp;gt;Arsine Medical Management Guidelines. Agency for Toxic Substances and Disease Registry (ATSDR). CDC.&amp;lt;...&amp;quot;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;Arsine gas (AsH₃) is the most acutely toxic form of arsenic. It is a colorless, nonirritating gas that causes '''massive intravascular hemolysis''' leading to '''acute renal failure''' and death. Arsine poisoning is '''distinct from inorganic arsenic poisoning''' — it does not produce classic arsenicosis, and '''chelation therapy is not effective.'''&amp;lt;ref name=&amp;quot;ATSDR&amp;quot;&amp;gt;Arsine Medical Management Guidelines. Agency for Toxic Substances and Disease Registry (ATSDR). CDC.&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Background==&lt;br /&gt;
*Arsine (AsH₃) is a colorless, heavier-than-air gas with a mild '''garlic-like or fishy odor''' (odor threshold ~0.5 ppm)&lt;br /&gt;
*'''Warning properties are inadequate''' — toxic effects occur at or below the concentration at which odor is detectable&amp;lt;ref name=&amp;quot;ATSDR&amp;quot;/&amp;gt;&lt;br /&gt;
*Arsine is '''extremely flammable''' and decomposes above 230°C (446°F)&lt;br /&gt;
*Sources of exposure:&lt;br /&gt;
**'''Occupational (most common):''' semiconductor/microchip manufacturing (gallium arsenide wafer production), metal smelting and refining, lead/zinc/copper ore processing, battery manufacturing, soldering, galvanizing&lt;br /&gt;
**Generated when arsenic-containing metals contact '''acid''' or '''water/moisture''' — may be produced unexpectedly during industrial processes&amp;lt;ref name=&amp;quot;Fowler1974&amp;quot;&amp;gt;Fowler BA, Weissberg JB. Arsine poisoning. ''N Engl J Med''. 1974;291(22):1171-1174. doi:10.1056/NEJM197411282912207&amp;lt;/ref&amp;gt;&lt;br /&gt;
**Cleaning of tanks, drums, or pipes that contained arsenic-bearing materials&lt;br /&gt;
*'''Extremely toxic:'''&amp;lt;ref name=&amp;quot;Medscape&amp;quot;&amp;gt;Arsine Poisoning Clinical Presentation. ''Medscape''. 2024.&amp;lt;/ref&amp;gt;&lt;br /&gt;
**150-250 ppm: immediately fatal&lt;br /&gt;
**25-50 ppm for 30 minutes: massive hemolysis, potentially fatal&lt;br /&gt;
**10 ppm: delirium&lt;br /&gt;
**3 ppm for several hours: symptomatic&lt;br /&gt;
**0.15 ppm: may produce mild symptoms&lt;br /&gt;
*Prior to the advent of hemodialysis, arsine-induced renal failure was '''100% fatal'''&amp;lt;ref name=&amp;quot;Medscape&amp;quot;/&amp;gt;&lt;br /&gt;
*Current mortality rate approximately 25% with modern ICU care&lt;br /&gt;
&lt;br /&gt;
===Mechanism of toxicity===&lt;br /&gt;
*Arsine is rapidly absorbed through the lungs and binds to hemoglobin in red blood cells&lt;br /&gt;
*Causes '''rapid, massive intravascular hemolysis''' through oxidative damage to RBC membranes&amp;lt;ref name=&amp;quot;Fowler1974&amp;quot;/&amp;gt;&lt;br /&gt;
**Arsine depletes reduced glutathione in erythrocytes&lt;br /&gt;
**Generates reactive oxygen species → lipid peroxidation of RBC membranes → membrane rupture&lt;br /&gt;
**Persons with '''[[G6PD deficiency]]''' are more susceptible to hemolysis&amp;lt;ref name=&amp;quot;R7&amp;quot;&amp;gt;Region VII Disaster Health Response Ecosystem. Hazardous Materials Guideline: Arsine. 2024.&amp;lt;/ref&amp;gt;&lt;br /&gt;
*Free hemoglobin released from hemolyzed RBCs → precipitates in renal tubules → '''acute tubular necrosis (ATN)''' and '''oliguric renal failure'''&lt;br /&gt;
*Arsine may also exert '''direct nephrotoxicity''' by inhibiting renal tubular cell respiration, independent of hemoglobin deposition&amp;lt;ref name=&amp;quot;Haddad&amp;quot;&amp;gt;Pigott DC, Liebelt EL. Arsine. In: Haddad and Winchester's Clinical Management of Poisoning and Drug Overdose. 4th ed. 2007.&amp;lt;/ref&amp;gt;&lt;br /&gt;
*'''Arsine does NOT produce classic arsenic intoxication''' — the pathophysiology is fundamentally different&amp;lt;ref name=&amp;quot;ATSDR&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Healthcare worker safety===&lt;br /&gt;
*Small amounts of arsine may be trapped in victim's clothing/hair after massive exposure, but quantities are '''unlikely to create significant hazard''' for hospital personnel away from the scene&amp;lt;ref name=&amp;quot;ATSDR&amp;quot;/&amp;gt;&lt;br /&gt;
*Patients exposed '''only to arsine gas''' do not require decontamination&lt;br /&gt;
*Use standard precautions; chemical-protective clothing generally not required for gas exposure&lt;br /&gt;
*SCBA required for responders at the scene&lt;br /&gt;
&lt;br /&gt;
==Clinical features==&lt;br /&gt;
*'''Patients may appear initially well''' — symptoms may be delayed 2-24 hours after exposure&amp;lt;ref name=&amp;quot;ATSDR&amp;quot;/&amp;gt;&lt;br /&gt;
*The classic triad is: '''garlic/fishy odor + dark red/brown urine (hemoglobinuria) + jaundice'''&lt;br /&gt;
&lt;br /&gt;
===Early symptoms (30 minutes - several hours)===&lt;br /&gt;
*Malaise, fatigue, headache&lt;br /&gt;
*Nausea, vomiting, crampy abdominal pain (among the earliest signs)&lt;br /&gt;
*Thirst, shivering&lt;br /&gt;
*Dyspnea&lt;br /&gt;
*'''Garlic-like or fishy odor''' on breath (may not be detectable)&lt;br /&gt;
&lt;br /&gt;
===Hemolytic phase (hours to 24 hours)===&lt;br /&gt;
*'''&amp;quot;Blackwater&amp;quot; urine''' — dark red, brown, or port wine–colored urine from '''hemoglobinuria''' (classic finding)&amp;lt;ref name=&amp;quot;Medscape&amp;quot;/&amp;gt;&lt;br /&gt;
*'''Jaundice''' (from hemolysis; may develop within 24-48 hours)&lt;br /&gt;
*Rapidly progressive anemia (hemoglobin may drop below 10 g/dL)&lt;br /&gt;
*Tachycardia&lt;br /&gt;
*Pallor progressing to bronze-yellow skin discoloration (jaundice + anemia)&lt;br /&gt;
*Hemolysis may continue for up to '''96 hours''' after exposure&amp;lt;ref name=&amp;quot;R7&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Renal phase (24-72+ hours)===&lt;br /&gt;
*'''Oliguria/anuria''' — acute renal failure may not be evident until up to 72 hours after exposure&amp;lt;ref name=&amp;quot;ATSDR&amp;quot;/&amp;gt;&lt;br /&gt;
*Flank pain (renal capsular distension)&lt;br /&gt;
*Fluid overload, pulmonary edema&lt;br /&gt;
*Uremia&lt;br /&gt;
&lt;br /&gt;
===Cardiac===&lt;br /&gt;
*'''Hyperkalemia''' (from massive hemolysis + renal failure) → peaked T waves, conduction blocks, cardiac arrest&amp;lt;ref name=&amp;quot;Haddad&amp;quot;/&amp;gt;&lt;br /&gt;
*ECG: high-peaked T waves, nonspecific ST-T changes, various degrees of heart block&lt;br /&gt;
*Direct myocardial toxicity may also contribute&lt;br /&gt;
&lt;br /&gt;
===Neurologic (delayed, weeks to months)===&lt;br /&gt;
*'''Peripheral neuropathy''' — may develop 1-6 months after acute exposure (similar to inorganic arsenic)&amp;lt;ref name=&amp;quot;ATSDR&amp;quot;/&amp;gt;&lt;br /&gt;
*Encephalopathy, cognitive changes, psychiatric disturbances&lt;br /&gt;
&lt;br /&gt;
==Differential diagnosis==&lt;br /&gt;
===Intravascular hemolysis (other causes)===&lt;br /&gt;
*[[G6PD deficiency]] with oxidant exposure&lt;br /&gt;
*[[Copper sulfate poisoning]]&lt;br /&gt;
*[[Transfusion reaction]]&lt;br /&gt;
*[[Malaria]]&lt;br /&gt;
*[[Hemolytic uremic syndrome]]&lt;br /&gt;
*[[Thrombotic thrombocytopenic purpura]]&lt;br /&gt;
*[[Wilson disease]]&lt;br /&gt;
*Paroxysmal nocturnal hemoglobinuria&lt;br /&gt;
&lt;br /&gt;
===Other toxic gas exposures===&lt;br /&gt;
*[[Carbon monoxide poisoning]]&lt;br /&gt;
*[[Cyanide poisoning]]&lt;br /&gt;
*[[Hydrogen sulfide poisoning]]&lt;br /&gt;
*[[Phosphine poisoning]] ([[Aluminum phosphide poisoning]], [[Zinc phosphide poisoning]])&lt;br /&gt;
&lt;br /&gt;
===Other causes of dark/bloody urine===&lt;br /&gt;
*[[Rhabdomyolysis]] (myoglobinuria)&lt;br /&gt;
*[[Hematuria]] (other causes)&lt;br /&gt;
&lt;br /&gt;
==Evaluation==&lt;br /&gt;
===Workup===&lt;br /&gt;
*'''CBC with peripheral smear:'''&amp;lt;ref name=&amp;quot;Haddad&amp;quot;/&amp;gt;&lt;br /&gt;
**Anemia (may be severe; hemoglobin &amp;lt;10 g/dL)&lt;br /&gt;
**Reticulocytosis, leukocytosis&lt;br /&gt;
**Peripheral smear: RBC fragments, '''ghost cells''', anisocytosis, poikilocytosis, basophilic stippling&lt;br /&gt;
**Blue-green cast to WBC nuclei on unstained preparations (reported but uncommon)&lt;br /&gt;
*'''Hemolysis markers:'''&lt;br /&gt;
**Plasma free hemoglobin — elevated&lt;br /&gt;
**'''Haptoglobin''' — decreased or undetectable&lt;br /&gt;
**'''LDH''' — markedly elevated&lt;br /&gt;
**Indirect bilirubin — elevated&lt;br /&gt;
**'''Direct Coombs test — NEGATIVE''' (critical: this is Coombs-negative hemolytic anemia; distinguishes from immune-mediated hemolysis)&amp;lt;ref name=&amp;quot;Haddad&amp;quot;/&amp;gt;&lt;br /&gt;
*'''Urinalysis:'''&lt;br /&gt;
**'''Hemoglobinuria''' — urine dipstick positive for blood, but no RBCs on microscopy&lt;br /&gt;
**Tubular casts&lt;br /&gt;
*'''BMP:''' renal function (BUN, creatinine), '''potassium''' (expect hyperkalemia)&lt;br /&gt;
*'''Hepatic function panel:''' may show elevated transaminases, bilirubin&lt;br /&gt;
*'''ECG:''' monitor for hyperkalemia-related changes (peaked T waves, widened QRS, heart block)&lt;br /&gt;
*'''Chest radiograph:''' pulmonary edema if fluid overloaded&lt;br /&gt;
*'''Urinary arsenic:''' may be elevated for weeks after exposure; provides index of exposure extent but does not guide acute management&amp;lt;ref name=&amp;quot;ATSDR&amp;quot;/&amp;gt;&lt;br /&gt;
*'''Blood arsenic:''' may be elevated acutely (&amp;lt;2 days post-exposure); clears rapidly from blood&lt;br /&gt;
*'''Type and screen''' — anticipate need for transfusion or exchange transfusion&lt;br /&gt;
*'''Serum electrolytes, calcium''' — monitor frequently&lt;br /&gt;
&lt;br /&gt;
===Diagnosis===&lt;br /&gt;
*Clinical: '''occupational exposure + garlic odor + dark urine + Coombs-negative hemolytic anemia + renal failure'''&lt;br /&gt;
*Even if arsine odor was '''not''' detected at the scene, exposure may still be significant&amp;lt;ref name=&amp;quot;ATSDR&amp;quot;/&amp;gt;&lt;br /&gt;
*High index of suspicion in any industrial worker with unexplained hemolysis&lt;br /&gt;
&lt;br /&gt;
==Management==&lt;br /&gt;
'''There is no specific antidote for arsine poisoning.''' Treatment is supportive care focused on protecting renal function and managing hemolysis.&amp;lt;ref name=&amp;quot;ATSDR&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
===Resuscitation===&lt;br /&gt;
*Airway, breathing, circulation per standard protocols&lt;br /&gt;
*Supplemental oxygen&lt;br /&gt;
*IV access; continuous cardiac monitoring&lt;br /&gt;
&lt;br /&gt;
===Decontamination===&lt;br /&gt;
*Patients exposed '''only to arsine gas''' do '''not''' require decontamination&amp;lt;ref name=&amp;quot;ATSDR&amp;quot;/&amp;gt;&lt;br /&gt;
*Remove contaminated clothing only if liquid arsine (compressed gas) exposure or co-exposure to arsenic-containing materials&lt;br /&gt;
*Irrigate eyes with water if exposed to liquid&lt;br /&gt;
&lt;br /&gt;
===Renal protection (critical)===&lt;br /&gt;
*'''Aggressive IV fluid resuscitation''' to maintain high urine output (target 2-3 mL/kg/hr)&amp;lt;ref name=&amp;quot;ATSDR&amp;quot;/&amp;gt;&lt;br /&gt;
*'''Urinary alkalinization:''' add 50-100 mEq NaHCO₃ to 1 L of D5W 0.25 NS; infuse to maintain urine pH &amp;gt;7.5 until urine is hemoglobin-free&lt;br /&gt;
**Rationale: alkaline urine reduces hemoglobin precipitation in renal tubules&lt;br /&gt;
**Note: the role of alkalinization is somewhat controversial but widely recommended&amp;lt;ref name=&amp;quot;Haddad&amp;quot;/&amp;gt;&lt;br /&gt;
*'''Low-dose dopamine''' may help preserve renal blood flow (limited evidence)&lt;br /&gt;
*'''Hemodialysis''' if acute renal failure develops&amp;lt;ref name=&amp;quot;ATSDR&amp;quot;/&amp;gt;&lt;br /&gt;
**Does '''not''' effectively remove arsine-hemoglobin or arsine-haptoglobin complexes&lt;br /&gt;
**Indicated for standard renal failure indications: uremia, hyperkalemia, volume overload, acidosis&lt;br /&gt;
&lt;br /&gt;
===Hemolysis management===&lt;br /&gt;
*'''Exchange transfusion:''' considered the most effective intervention for severe hemolysis&amp;lt;ref name=&amp;quot;Haddad&amp;quot;/&amp;gt;&lt;br /&gt;
**Removes free hemoglobin, arsine-damaged RBCs, and hemoglobin-haptoglobin complexes from circulation&lt;br /&gt;
**Reduces renal hemoglobin load&lt;br /&gt;
**Should be considered early in patients with massive hemolysis&lt;br /&gt;
*'''Packed RBC transfusion:''' for symptomatic anemia; adequate for mild hemolysis&amp;lt;ref name=&amp;quot;Haddad&amp;quot;/&amp;gt;&lt;br /&gt;
*Monitor serial hemoglobin/hematocrit (hemolysis may progress for up to 96 hours)&lt;br /&gt;
&lt;br /&gt;
===Hyperkalemia===&lt;br /&gt;
*Aggressive management per standard protocols (calcium gluconate, insulin/dextrose, sodium bicarbonate, kayexalate, hemodialysis)&lt;br /&gt;
*May be severe due to combined massive hemolysis + renal failure&lt;br /&gt;
*Continuous cardiac monitoring&lt;br /&gt;
&lt;br /&gt;
===Chelation therapy===&lt;br /&gt;
*'''Chelation (BAL/dimercaprol) is NOT effective and NOT recommended for acute arsine poisoning'''&amp;lt;ref name=&amp;quot;ATSDR&amp;quot;/&amp;gt;&amp;lt;ref name=&amp;quot;Haddad&amp;quot;/&amp;gt;&lt;br /&gt;
**BAL does '''not''' prevent or reduce hemolysis even when given soon after exposure&lt;br /&gt;
**Chelation addresses inorganic arsenic toxicity, not arsine's hemolytic mechanism&lt;br /&gt;
**Unlike [[Arsenic poisoning|inorganic arsenic poisoning]], chelation should '''not''' be used routinely&lt;br /&gt;
&lt;br /&gt;
==Disposition==&lt;br /&gt;
*'''All symptomatic patients and all patients with significant exposure history:''' admit to ICU&amp;lt;ref name=&amp;quot;Haddad&amp;quot;/&amp;gt;&lt;br /&gt;
**Continuous cardiac monitoring&lt;br /&gt;
**Hourly urine output monitoring for at least 24 hours&lt;br /&gt;
**Serial CBC, hemolysis markers, renal function, potassium every 4-6 hours initially&lt;br /&gt;
*'''Asymptomatic patients with possible exposure:''' observe for '''minimum 24 hours''' with serial labs&amp;lt;ref name=&amp;quot;ATSDR&amp;quot;/&amp;gt;&lt;br /&gt;
**Onset of hemolysis may be delayed up to 24 hours&lt;br /&gt;
**Acute renal failure may not be evident for up to 72 hours&lt;br /&gt;
*'''Patients with no signs of hemolysis after 24 hours of observation:''' may discharge with close follow-up and return precautions&amp;lt;ref name=&amp;quot;ATSDR&amp;quot;/&amp;gt;&lt;br /&gt;
*'''Outpatient follow-up should include:'''&lt;br /&gt;
**Serial renal function monitoring&lt;br /&gt;
**Monitoring for delayed '''peripheral neuropathy''' (may appear 1-6 months post-exposure)&lt;br /&gt;
**Neuropsychiatric evaluation for possible encephalopathy&lt;br /&gt;
*Recovery from severe arsine poisoning may take '''weeks to months'''&lt;br /&gt;
*Contact [[Poison control]] (1-800-222-1222 in the US) for all cases&lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
*[[Arsenic poisoning]]&lt;br /&gt;
*[[Carbon monoxide poisoning]]&lt;br /&gt;
*[[Cyanide poisoning]]&lt;br /&gt;
*[[Hydrogen sulfide poisoning]]&lt;br /&gt;
*[[Aluminum phosphide poisoning]]&lt;br /&gt;
*[[Zinc phosphide poisoning]]&lt;br /&gt;
*[[Copper sulfate poisoning]]&lt;br /&gt;
*[[Rhabdomyolysis]]&lt;br /&gt;
*[[Acute kidney injury]]&lt;br /&gt;
*[[Hyperkalemia]]&lt;br /&gt;
&lt;br /&gt;
==External Links==&lt;br /&gt;
*[https://wwwn.cdc.gov/TSP/MMG/MMGDetails.aspx?mmgid=1199&amp;amp;toxid=278 ATSDR — Arsine Medical Management Guidelines]&lt;br /&gt;
*[https://www.ncbi.nlm.nih.gov/books/NBK222407/ NCBI — Arsine Acute Exposure Guideline Levels]&lt;br /&gt;
*[https://emedicine.medscape.com/article/833740-clinical Medscape — Arsine Poisoning Clinical Presentation]&lt;br /&gt;
*[https://www.nejm.org/doi/full/10.1056/NEJM197411282912207 NEJM — Arsine Poisoning (Fowler &amp;amp; Weissberg, 1974)]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
&amp;lt;references/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
[[Category:Toxicology]]&lt;/div&gt;</summary>
		<author><name>Ostermayer</name></author>
	</entry>
</feed>